China Hastens New Drug Development, Bayer Starts 20 New Clinical Trials
This article was originally published in PharmAsia News
Bayer HealthCare China President Li Xilie, revealed April 28 that Bayer Schering Pharma started 20 new drug clinical trials in China last year
You may also be interested in...
Bayer Schering Forges Women's Health Research Partnership With Beijing's People's Liberation Army General Hospital
PERTH, Australia - Bayer Schering Pharma AG has forged a long-term strategic research partnership in the area of women's health with the People's Liberation Army General Hospital, known as 301 Hospital, in Beijing
Coverage Decisions For AlloMap Molecular Testing To Detect Cardiac Allograft Rejections Left Up To MACs
The US CMS has proposed that due to low Medicare use, it will not nationally cover AlloMap molecular tests to detect cardiac allograft rejections.
Manufacturers considering use of the popular 99.99% germ-kill claim on hand sanitizer products should consult the Office of Compliance, said Division of Nonprescription Drug Products director Theresa Michele during a recent industry workshop. “Be very, very cautious about the claims you are making,” she said.